Skip to main content

Find Clinical Trials

Home
Conditions
MSI Solid Tumors Refractory to PD1/PDL1 Antibody Monotherapy

Clinical trial condition

MSI Solid Tumors Refractory to PD1/PDL1 Antibody Monotherapy

Explore clinical trials studying MSI Solid Tumors Refractory to PD1/PDL1 Antibody Monotherapy. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

MSI Solid Tumors Refractory to PD1/PDL1 Antibody Monotherapy trial results

Recruiting

A Biomarker Exploratory Study of Dual Blockade of PD1/PDL1 and CTLA4 and Anti-angiogenic Therapy

NCT06549907

Conditions: MSI Solid Tumors Refractory to PD1/PDL1 Antibody Monotherapy, MSS Metastatic Colorectal Cancers
Locations: Jian Li Beijing, Beijing Municipality, China

View Trial Details

MSS Metastatic Colorectal Cancers (1)